Hefei Lifeon Pharmaceutical Co., Ltd. (SZSE: 003020)
Health Care · Pharmaceuticals · CN
CN¥17.26
+1.59% today · -25.6% 1Y
Hefei Lifeon Pharmaceutical Co., Ltd. (SZSE: 003020) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $587.23M and employs 1,465 people.
Over the last twelve months the share price has lost 25.6%, trading between 14.20 and 27.01.
Tweenvest scores Hefei Lifeon Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 43/100, growth 28/100, dividend 74/100. Its strongest factor is dividend.
003020 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $587.23M
- Revenue (TTM)
- $221.65M
- P/E
- 24.10
- EPS
- 0.72
- Dividend yield
- 2.41%
- Beta (5Y)
- -0.14
- 52-week high
- CN¥27.01
- 52-week low
- CN¥14.20
- Avg volume (3M)
- —
- Shares outstanding
- 228.22M
- Employees
- 1,465
- Next earnings
- —
About Hefei Lifeon Pharmaceutical Co., Ltd.
Hefei Lifeon Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a wide array of pharmaceutical goods. Its product portfolio encompasses active pharmaceutical ingredients (APIs) such as succimer, urea, paeonol, felodipine, doxazosin mesylate, zofenopril calcium, troxerutin, and sodium 2,3-dimercapto-1-propanesulfonate. The company also manufactures various medicinal preparations, including felodipine sustained-release tablets, doxazosin mesylate extended-release tablets, melbinum glipizide tablets, yiqihewei capsules, kunning granules, armillariella oral solution, paeonol ointment, urea and vitamin E cream, Kecuo Yintong gel, and Compound Golden Larch bark gel. Additionally, Hefei Lifeon Pharmaceutical supplies plant extracts like clove oil, evening primrose oil, herba clinopodii P.E, quercetin, and dihydroquercetin. Beyond its manufacturing operations, the company operates a retail chain for pharmaceuticals. Established in 2002, Hefei Lifeon Pharmaceutical Co., Ltd. is headquartered in Hefei, China.
- ISIN
- CNE100004BD9
- Founded
- 2002
- Listed since
- Dec 15, 2020
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.SHSE: 600613 | $609.32M | CN¥8.19 | -0.73% |
| Jinling Pharmaceutical Company LimitedSZSE: 000919 | $602.66M | CN¥6.50 | +1.25% |
| Zevra Therapeutics, Inc.NasdaqGS: ZVRA | $593.24M | $11.00 | +10.11% |
| Beijing Tong Ren Tang Chinese Medicine Company LimitedSEHK: 3613 | $593.03M | HK$5.56 | +1.74% |
| Shanghai Xiao Fang Pharmaceutical Co.,Ltd.SHSE: 603207 | $585.90M | CN¥24.46 | +0.87% |
| Tibet Weixinkang Medicine Co., Ltd.SHSE: 603676 | $585.87M | CN¥9.09 | +2.71% |
| Jinhe Biotechnology CO., LTD.SZSE: 002688 | $585.82M | CN¥5.20 | +0.97% |
| Xiangxue Pharmaceutical Co.,Ltd.SZSE: 300147 | $581.64M | CN¥5.90 | +4.98% |
Figures last refreshed Oct 4, 2026.